| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/15/2006 | WO2004090113A3 L53, a lung cancer associated antigen and uses thereof |
| 06/15/2006 | WO2004087887A3 Intracellular complexes as biomarkers |
| 06/15/2006 | WO2004083390A3 Virulent systemic feline calicivirus |
| 06/15/2006 | US20060130164 Toll/interleukin-1 receptor adapter protein (TIRAP) |
| 06/15/2006 | US20060128742 Cell migration inhibiting compositions and methods and compositions for treating cancer |
| 06/15/2006 | US20060128644 Use of mob-5 in pain |
| 06/15/2006 | US20060128607 Method for inhibiting "melanoma inhibitory activity" mia |
| 06/15/2006 | US20060127984 Modified Vaccinia virus Ankara for the vaccination of neonates |
| 06/15/2006 | US20060127979 Capable of generating high titer neutralizing antibody responses against at least two HPV types; prophylactic agents; diagnosis |
| 06/15/2006 | US20060127959 Antibodies that bind M. tuberculosis polypeptides |
| 06/15/2006 | US20060127955 Assay for autoantibodies to folate receptors |
| 06/15/2006 | US20060127927 Mammalian IAP gene family, primers, probes, and detection methods |
| 06/15/2006 | US20060127897 Delete sequence in m, tuberculosis, method for detecting mycobacteria using these sequences and vaccines |
| 06/15/2006 | US20060127894 Protein associated with cell growth, differentiation, and death |
| 06/15/2006 | US20060127873 Composition for cytocompatible, injectable, self-gelling chitosan solutions for encapsulating and delivering live cells or biologically active factors |
| 06/15/2006 | US20060127419 Process for the production of temperature-induced tumor cell lysates for use as immunogenic compounds |
| 06/15/2006 | US20060127418 Composition containing Leishmania Lip2a |
| 06/15/2006 | US20060127417 administering the toxin directly to a blood vessel, especially following a cardiovascular procedure. |
| 06/15/2006 | US20060127416 Polynucleotide encoding a protein believed to be highly immunogenic, especially in fish, and also has utility as a non-specific adjuvant, and as an adjuvanting carrier for heterologous antigens. |
| 06/15/2006 | US20060127415 Drying process |
| 06/15/2006 | US20060127414 Immunogenic Composition |
| 06/15/2006 | US20060127413 Recombinant mva strains as potential vaccines against p. falciparum malaria |
| 06/15/2006 | US20060127411 Immune -modulating peptide made of s.aureus enterotoxin b |
| 06/15/2006 | US20060127410 diagnosing measles virus infection or immunity to measles virus in a human patient, by analyzing the sample from patients for the presence of the peptides or antibodies to the peptide |
| 06/15/2006 | US20060127409 Bcr-abl vaccines and methods of use thereof |
| 06/15/2006 | US20060127408 Cancer immunotherapy |
| 06/15/2006 | US20060127407 Anti-integrin immunoconjugates, methods and uses |
| 06/15/2006 | US20060127406 Enriched antibody for detecting mycobacterial infection, methods of use and diagnostic test employing same |
| 06/15/2006 | US20060127405 Specifically recognizing human oculospanin and having cytotoxic activity against cancer cells, cancer therapy |
| 06/15/2006 | US20060127404 Hinge core mimetibodies, compositions, methods and uses |
| 06/15/2006 | US20060127403 Use of antibodies against tumor-associated antigen |
| 06/15/2006 | US20060127402 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors |
| 06/15/2006 | US20060127401 Screening method |
| 06/15/2006 | US20060127400 Activation of regulatory T cells by alpha-melanocyte stimulating hormone |
| 06/15/2006 | US20060127399 Compositions and methods for inducing chimerism in a subject |
| 06/15/2006 | US20060127398 Monoclonal antibody capable of binding integrin alpha 10 beta 1 |
| 06/15/2006 | US20060127397 RAG polypeptides, nucleic acids, and their use |
| 06/15/2006 | US20060127396 Peptide fragment of lyve-1 and antibody against the same |
| 06/15/2006 | US20060127395 comprising an E25 anti-IgE antibody and acetic acid ; nasal sprays and slow release formulations drying or freeze-drying; treating an allergic disease |
| 06/15/2006 | US20060127394 Cloning of honey bee allergen |
| 06/15/2006 | US20060127393 antibodies and antigen binding domains and CDR regions that mediate selective binding to an epitope located in the carboxyl half of the Dkk-1 protein; for bone disorders, inflammatory, neurological, ocular, renal, pulmonary and skin diseases |
| 06/15/2006 | US20060127392 Antibody for adcc and inducing cytokine production |
| 06/15/2006 | US20060127391 Methods and materials for treating inflammatory conditions |
| 06/15/2006 | US20060127360 Multi-antigen vectors of melanoma |
| 06/15/2006 | US20060127357 Rapamycin and il-10 for the treatment of immune diseases |
| 06/15/2006 | US20060127356 Single-stranded polynucleotides that code for human melanoma antigen(MAGE) and human leukocyte antigens, used in gene therapy and medical diagnosis; immunology |
| 06/15/2006 | US20060127352 Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds |
| 06/15/2006 | US20060127327 Monoclonal antibodies specific for cariogenic bacteria |
| 06/15/2006 | US20060127310 Amplification of biotin-mediated targeting |
| 06/15/2006 | CA2630088A1 Signal peptides, nucleic acid molecules and methods of treatment |
| 06/15/2006 | CA2623753A1 Peptides which mimic the antigenic regions of the hepatitis a virus |
| 06/15/2006 | CA2614574A1 Cytotoxic agents comprising new c-2 modified taxanes |
| 06/15/2006 | CA2600898A1 Novel cancer antigen peptide and the use thereof |
| 06/15/2006 | CA2593036A1 Methods of producing influenza vaccine compositions |
| 06/15/2006 | CA2591148A1 Anti-integrin immunoconjugates, methods and uses |
| 06/15/2006 | CA2590160A1 Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases |
| 06/15/2006 | CA2589981A1 Combination of tyrosine kinase inhibitor and her-2/neu for cancer therapy |
| 06/15/2006 | CA2588685A1 Alpha thymosin peptides as cancer vaccine adjuvants |
| 06/15/2006 | CA2588587A1 Cytotoxic agents comprising new taxanes |
| 06/15/2006 | CA2588270A1 Methods and compositions for treating ocular disorders |
| 06/15/2006 | CA2587143A1 Methods and compositions for immunotherapy and detection of inflammatory and immune-dysregulatory disease, infectious disease, pathologic angiogenesis and cancer |
| 06/15/2006 | CA2586690A1 Influenza vaccination |
| 06/15/2006 | CA2585104A1 Human monoclonal antibodies to influenza m2 protein and methods of making and using same |
| 06/14/2006 | EP1669448A1 Process for producing antigenic substance |
| 06/14/2006 | EP1669358A1 Cytotoxic agents comprising new taxanes |
| 06/14/2006 | EP1668142A1 Modified vaccinia virus ankara (mva) mutant and use thereof |
| 06/14/2006 | EP1668132A1 Cytokine involved in epithelial-mesenchymal transition |
| 06/14/2006 | EP1668114A2 Polypeptide display libraries and methods of making and using thereof |
| 06/14/2006 | EP1668112A2 Vectors expressing sars immunogens, compositions containing such vectors or expression products thereof, methods and essays for making and using |
| 06/14/2006 | EP1668036A2 High-yield method for the production of human antibodies blocking the biological activity of a human cytokine |
| 06/14/2006 | EP1668031A2 Homogeneous preparations of il-28 and il-29 |
| 06/14/2006 | EP1668029A2 East coast fever vaccine based on ctl-specific schizont antigens |
| 06/14/2006 | EP1667735A2 Inhibition of inward sodium currents in cancer |
| 06/14/2006 | EP1667720A1 Combination of a histone deacetylase inhibitor with a death receptor ligand |
| 06/14/2006 | EP1667718A2 Method of promoting graft survival with anti-tissue factor antibodies |
| 06/14/2006 | EP1667717A2 Therapeutic human anti-mhc class ii antibodies and their uses |
| 06/14/2006 | EP1667716A1 Cytotoxicity mediation of cells evidencing surface expression of cd44 |
| 06/14/2006 | EP1667715A2 Antigen delivery system |
| 06/14/2006 | EP1667714A2 Consensus/ancestral immunogens |
| 06/14/2006 | EP1667713A1 Measles subunit vaccine |
| 06/14/2006 | EP1667712A2 B. pertussis antigens and use thereof in vaccination |
| 06/14/2006 | EP1667711A2 Preventive cancer vaccine based on brother of regulator of imprinted sites molecule (boris) |
| 06/14/2006 | EP1667710A2 Means and methods for the recruitment and identification of stem cells |
| 06/14/2006 | EP1667701A2 Tumor vaccine |
| 06/14/2006 | EP1667677A1 Composition for treating inflammatory bowel disease |
| 06/14/2006 | EP1667648A2 Compositions and methods for treating burns |
| 06/14/2006 | EP1667634A2 Anthrax vaccine |
| 06/14/2006 | EP1667631A2 Combination approaches for generating immune responses |
| 06/14/2006 | EP1667630A2 Methods and compositions for the prevention and treatment of genitourinary disorders, including pre-term labor and leiomyomas |
| 06/14/2006 | EP1667619A1 Pharmaceutical delivery system |
| 06/14/2006 | EP1667523A2 Dna vaccine compositions and methods of use |
| 06/14/2006 | EP1427420B1 Use of a combination comprising 4-pyridylmethylphthalazines for cancer treatment |
| 06/14/2006 | EP1379650B1 Preferred segments of neural thread protein and methods of using the same |
| 06/14/2006 | EP1341819B1 Use of fibrin/fibrinogen peptides and proteins for the manufacture of a medicament |
| 06/14/2006 | EP1309703B1 Kallikrein gene |
| 06/14/2006 | EP1278825B1 Methods of producing membrane vesicles |
| 06/14/2006 | EP1255558B1 Anti-april antibodies and hybridoma cells |
| 06/14/2006 | EP1119370B1 Reversal of viral-induced systemic shock and respiratory distress by blockade of the lymphotoxin beta pathway |
| 06/14/2006 | EP1102596B1 Peptide antagonists of zonulin and methods for use of the same |
| 06/14/2006 | EP1097210B1 Immunological reagent specifically interacting with the extracellular domain of the human zeta chain |